Skip to main content
Back
FDMDF logo

4DMedical Limited

Data quality: 100%
FDMDF
OTC Healthcare Medical - Devices
$3.16
$0.00 (0.00%)
Mkt Cap: 1.81B
Day Range
$2.35 $3.16
52-Week Range
$0.16 $3.33
Volume
2,127
50D / 200D Avg
$2.71 / $1.37
Prev Close
$3.16

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -60.4 0.4
P/B 28.3 2.9
ROE % -44.5 3.8
Net Margin % -513.7 3.9
Rev Growth 5Y % 127.9 10.0
D/E 0.1 0.2

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2029 $0.02
$0.01 – $0.03
 110 M 1
FY2028 -$0.01
-$0.01 – $0.00
 65 M 1
FY2027 -$0.04
-$0.07 – -$0.03
 33 M 1

Key Takeaways

Revenue grew 127.90% annually over 5 years — strong growth
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -34.56M
PEG of 0.07 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 35.96%
Capital efficient — spends only 1.47% of revenue on capex

Growth

Revenue Growth (5Y)
127.90%
Revenue (1Y)91.94%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-44.49%
ROIC-31.97%
Net Margin-513.72%
Op. Margin-499.20%

Safety

Debt / Equity
0.07
Current Ratio0.89
Interest Coverage0.00

Valuation

P/E Ratio
-60.36
P/B Ratio28.26
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 91.94% Revenue Growth (3Y) 185.41%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 127.90% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5.85M Net Income (TTM) -30.07M
ROE -44.49% ROA -31.72%
Gross Margin 92.07% Operating Margin -499.20%
Net Margin -513.72% Free Cash Flow (TTM) -34.56M
ROIC -31.97% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.07 Current Ratio 0.89
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -60.36 P/B Ratio 28.26
P/S Ratio 310.07 PEG Ratio 0.07
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.81B Enterprise Value 1.81B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.85M 3.05M 718,581.0 1.05M 216,978.0
Net Income -30.07M -35.98M -31.46M -24.59M -21.42M
EPS (Diluted) -0.14 -0.10 -0.10 -0.08 -0.08
Gross Profit 5.39M 2.81M -24.28M 280,617.0 125,125.0
Operating Income -29.22M -46.61M -30.65M -22.20M -13.69M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 94.81M 120.02M 92.92M 74.31M 92.64M
Total Liabilities 30.58M 49.09M 21.46M 14.80M 9.28M
Shareholders' Equity 64.24M 70.93M 71.46M 59.51M 83.36M
Total Debt 4.31M 5.12M 5.14M 6.24M 1.69M
Cash & Equivalents 6.88M 30.61M 69.58M 51.11M 80.88M
Current Assets 17.06M 39.05M 78.54M 58.85M 85.85M
Current Liabilities 19.25M 21.89M 17.07M 9.56M 8.17M

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#50 of 146
52

Recent Activity

Entered Full Throttle
Mar 24, 2026